Capital Wealth Planning’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.13M | Buy |
+45,286
| New | +$3.13M | 0.02% | 76 |
|
|
2025
Q1 | – | Sell |
-20,792
| Closed | -$1.79M | – | 156 |
|
|
2024
Q4 | $1.79M | Sell |
20,792
-1,100
| -5% | -$94.6K | 0.02% | 79 |
|
|
2024
Q3 | $2.61M | Sell |
21,892
-1,914
| -8% | -$228K | 0.02% | 66 |
|
|
2024
Q2 | $3.4M | Buy |
23,806
+15,731
| +195% | +$2.25M | 0.04% | 47 |
|
|
2024
Q1 | $1.04M | Buy |
8,075
+511
| +7% | +$65.6K | 0.01% | 86 |
|
|
2023
Q4 | $782K | Buy |
+7,564
| New | +$782K | 0.01% | 95 |
|
|
2023
Q2 | – | Sell |
-8,052
| Closed | -$641K | – | 144 |
|
|
2023
Q1 | $641K | Buy |
+8,052
| New | +$641K | 0.01% | 67 |
|